Adherence styles of schizophrenia patients identified by a latent class analysis of the Medication Adherence Rating Scale (MARS): A six-month follow-up study

被引:25
作者
Jaeger, Susanne [1 ]
Pfiffner, Carmen [1 ]
Weiser, Prisca [2 ]
Kilian, Reinhold [2 ]
Becker, Thomas [2 ]
Laengle, Gerhard [3 ]
Eschweiler, Gerhard Wilhelm [3 ]
Croissant, Daniela
Schepp, Wiltrud [4 ]
Steinert, Tilman [1 ]
机构
[1] Univ Ulm, Dept Psychiat & Psychotherapy 1, Zentrum Psychiat Sudwurttemberg, D-88214 Ravensburg, Germany
[2] Univ Ulm, Dept Psychiat & Psychotherapy 2, Bkh Gunzburg, Germany
[3] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany
[4] Bezirksklinikum Regensburg, Dept Forens Psychiat & Psychotherapy, Regensburg, Germany
关键词
Psychosis; Schizophrenia; Compliance; Antipsychotics; LCA; PREDICTIVE-VALIDITY; RELIABILITY; VALIDATION; VERSION;
D O I
10.1016/j.psychres.2012.03.033
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The purpose of this study was to examine patients' response profiles to the Medication Adherence Rating Scale (MARS) and to evaluate the potential of response styles as predictors of the future course of psychotic disorders in terms of rehospitalisation and maintenance of medication. A total of 371 psychiatric in-patients with schizophrenia or schizoaffective disorder who were taking part in a naturalistic long-term study completed a German version of the MARS. A Latent Class Analysis (LCA) was performed. Five latent classes of response styles could be identified: "moderately adherent", "critical discontinuers", "good compliers", "careless and forgetful", and "compliant sceptics". Class membership was found to be related to the severity of symptoms, level of functioning, insight into illness, insight into necessity of treatment, treatment satisfaction and medication side effects. At a six-month follow-up appointment, significant differences between the classes persisted. Participants showing a "good compliers" response pattern had a significantly better prognosis in terms of rehospitalisation rate and maintenance of the original medication than "critical discontinuers". Evaluation of the MARS by studying response profiles provides informative results that reach beyond the results obtained by an evaluation by scores. Patients can be classified into adherence groups that are of predictive value for long-term patient outcome. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 30 条
[21]  
Mitchell A.J., 2007, Advances in Psychiatric Treatment, V13, P336, DOI [DOI 10.1192/APT.BP.106.003194, 10.1192/apt.bp.106.003194]
[22]   CONCURRENT AND PREDICTIVE-VALIDITY OF A SELF-REPORTED MEASURE OF MEDICATION ADHERENCE [J].
MORISKY, DE ;
GREEN, LW ;
LEVINE, DM .
MEDICAL CARE, 1986, 24 (01) :67-74
[23]   Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients [J].
Rosa, Adriane Ribeiro ;
Marco, Marion ;
Fachel, Jandyra M. G. ;
Kapczinski, Flavio ;
Stein, Airton Tetelbom ;
Barros, Helena M. T. .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (01) :217-224
[24]   A fast, implementable psychoeducation program for schizophrenia [J].
Rummel-Kluge, Christine ;
Pitschel-Walz, Gabriele ;
Kissling, Werner .
PSYCHIATRIC SERVICES, 2007, 58 (09) :1226-1226
[25]  
Schnell T., 2010, NERVENARZT, V81, P32
[26]   Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses [J].
Thompson, K ;
Kulkarni, J ;
Sergejew, AA .
SCHIZOPHRENIA RESEARCH, 2000, 42 (03) :241-247
[27]   Defining and assessing adherence to oral antipsychotics: A review of the literature [J].
Velligan, Dawn I. ;
Lam, Yui-Wing Francis ;
Glahn, David C. ;
Barrett, Jennifer A. ;
Maples, Natalie J. ;
Ereshefsky, Larry ;
Miller, Alexander L. .
SCHIZOPHRENIA BULLETIN, 2006, 32 (04) :724-742
[28]   Assessment of Adherence Problems in Patients with Serious and Persistent Mental Illness: Recommendations from the Expert Consensus Guidelines [J].
Velligan, Dawn I. ;
Weiden, Peter J. ;
Sajatovic, Martha ;
Scott, Jan ;
Carpenter, Daniel ;
Ross, Ruth ;
Docherty, John P. .
JOURNAL OF PSYCHIATRIC PRACTICE, 2010, 16 (01) :34-45
[29]  
Viguera AC, 1997, ARCH GEN PSYCHIAT, V54, P49
[30]  
Wolzniak A, 2003, PHARMACOPSYCHIATRY, V36, P274